Escherichia coli and Klebsiella Vaccines and Immunotherapy
- 1 June 1990
- journal article
- review article
- Published by Elsevier in Infectious Disease Clinics of North America
- Vol. 4 (2) , 271-282
- https://doi.org/10.1016/s0891-5520(20)30341-x
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Oral Ciprofloxacin and a Monoclonal Antibody to Lipopolysaccharide Protect Leukopenic Rats from Lethal Infection with Pseudomonas aeruginosaThe Journal of Infectious Diseases, 1989
- Prevention ofHaemophilus influenzaeType b Infections in High-Risk Infants Treated with Bacterial Polysaccharide Immune GlobulinNew England Journal of Medicine, 1987
- TRANSFERABLE ENZYMATIC RESISTANCE TO THIRD-GENERATION CEPHALOSPORINS DURING NOSOCOMIAL OUTBREAK OF MULTIRESISTANT KLEBSIELLA PNEUMONIAEThe Lancet, 1987
- Safety and immunogenicity of a polyvalentKlebsiella capsular polysaccharide vaccine in humansVaccine, 1986
- Safety and Immunogenicity of Klebsiella pneumoniae K1 Capsular Polysaccharide Vaccine in HumansThe Journal of Infectious Diseases, 1985
- Treatment of Gram-Negative Bacteremia and Shock with Human Antiserum to a MutantEscherichia coliNew England Journal of Medicine, 1982
- HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOODThe Lancet, 1981
- Correlation between Serum IgG-2 Concentrations and the Antibody Response to Bacterial Polysaccharide AntigensNew England Journal of Medicine, 1980
- Analysis of Increasing Antibiotic Resistance of Klebsiella pneumoniae Relative to Changes in ChemotherapyThe Journal of Infectious Diseases, 1978
- Human Immunity to Pseudomonas aeruginosa. II. Relationship between Heat-Stable Opsonins and Type-Specific LipopolysaccharidesThe Journal of Infectious Diseases, 1972